Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Jane Kirby

Why the NHS Mounjaro rollout has been branded ‘unambitious’

  • A report by the Commons Health and Social Care Committee has warned that NHS plans to distribute the weight-loss drug Mounjaro are ‘unambitious’.
  • Only about six per cent of eligible patients, roughly 220,000 of the 2.8 million who qualify, will receive the drug via the NHS across its initial three years.
  • MPs warned that restricted NHS access has created a two-tier system where treatment depends on the ability to pay, entrenching health inequalities.
  • Committee chairwoman Layla Moran urged the government to treat obesity as a chronic condition similar to diabetes and host an urgent summit to accelerate GLP-1 drug rollout.
  • Pharmacy experts added that slow NHS provision risks pushing desperate patients towards dangerous black-market alternatives.

IN FULL

Mounjaro rollout on NHS is too slow and creating ‘two-tier system’, MPs warn

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.